PlexusDx offers flexibility in dosing strategy, including the Microdose GLP-1 Protocol ($129/mo), which prioritizes gentler metabolic change over rapid weight loss and may suit patients sensitive to hormonal disruption
The dual mechanism of tirzepatide produces greater average weight loss in clinical trials, approximately 22% body weight versus 15% for semaglutide
Does GLP1 therapy increase the risk of pancreatitis
For more information, read our post, Will Insurance Cover Ozempic for PCOS
In this study, we saw disruptions were particularly pronounced among AOM users, peaking in late 2023
If the reconstitution process feels intimidating at first, that discomfort is appropriate